NEW YORK and SINGAPORE, Feb 22 (Bernama-GLOBE NEWSWIRE) — Paratus Sciences Corporation, a biotechnology company accelerating the discovery of novel therapeutics by leveraging the extraordinary adaptive biology of bats, today announced it has appointed Theresa Heah, M.D., M.B.A. as Chief Executive Officer and a member of its Board of Directors.
“We are thrilled to have Dr. Heah assume the helm at Paratus,” said Amir Nashat, Executive Partner of Polaris Partners, chair of Paratus’s Board of Directors and the company’s founding CEO. “Theresa brings a tremendous wealth of experience as a seasoned pharma and biotech executive, having spearheaded the development and commercialization of multiple innovative therapies. She is well poised to guide Paratus as it continues to build its proprietary platform, advance its novel discovery portfolio, and grow its team and capabilities.”